Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer

Henneman, L.; Miltenburg, M.H. van; Michalak, E.M.; Braumuller, T.M.; Jaspers, J.E.; Drenth, A.P.; ... ; Jonkers, J. (2015)

Article / Letter to editor

• resistance
• mouse model
• breast cancer
• BRCA1
• PARP

• All authors: Henneman, L.; Miltenburg, M.H. van; Michalak, E.M.; Braumuller, T.M.; Jaspers, J.E.; Drenth, A.P.; Korte-Grimmerink, R. de; Gogola, E.; Szuhai, K.; Schlicker, A.; Ali, R. bin; Pritchard, C.; Huijbers, I.J.; Berns, A.; Rottenberg, S.; Jonkers, J.
• Date: 2015-07-07
• Journal: Proceedings of the National Academy of Sciences
• Volume: 112
• Issue: 27
• Pages: 8409 - 8414
• DOI: doi:10.1073/pnas.1500223112